Kavuru Vimal — SEC insider filings
SEC reporting owner CIK 1697184. 8 insider filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-11-16 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 676,371 shares, $1,249,934 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 676,371 shares @ $1.85 ($1,249,934) in Grace Therapeutics, Inc., filed 2023-09-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | Director | 8 | 1 leg · 676,371 sh · $1,249,934 | — | 8 |
Insider filings — Kavuru Vimal
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Grace Therapeutics, Inc. (GRCE) | Grant/award (A): 12,200 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Grace Therapeutics, Inc. (GRCE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Grace Therapeutics, Inc. (GRCE) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | Acasti Pharma Inc. (ACST) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-09-27 | 4 | Acasti Pharma Inc. (ACST) | Purchase (P): 676,371 @ $1.85 · Purchase (P): 422,732 (derivative) @ $0.12 | EDGAR |
| 2023-07-18 | 4 | Acasti Pharma Inc. (ACST) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | Acasti Pharma Inc. (ACST) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Acasti Pharma Inc. (ACST) | Grant/award (A): 42,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-11-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1697184 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs